HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Sys. Review
Case report and review: azacytidine plus ruxolitinib in connective tissue disease with CMML and myelofibrosis
A single patient found relief from blood cancer with a new drug combo
This case report and literature review describes a 52-year-old male with connective tissue disease, chronic myelomonocytic leukemia, and mye…
One man with blood cancer saw his fever and anemia improve after two years on a specific drug mix, offering a glimpse into potential new tre…
Frontiers
May 14, 2026
Allergy & Immunology
Meta-analysis
Systematic review and meta-analysis of ENA seropositivity in ANA-IIF-negative connective tissue disease populations
A Negative ANA Test Can Still Miss Autoimmune Disease, Study Finds
This systematic review and meta-analysis evaluated the frequency of extractable nuclear antigen (ENA) seropositivity among 28,552 ANA-IIF-ne…
A negative ANA test doesn't always rule out autoimmune disease, with 14% of negative cases still showing other key antibodies.
Frontiers
Apr 28, 2026